Study S002710

Complementary Effects of New Diabetes Medications on Adrenal Function and Intestinal Microbiota

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT04151849
Study type: OBSERVATIONAL
Status: COMPLETED
Enrollment: 23
Start: 2019-11-07
Primary completion: 2023-01-23
Lead sponsor: University of Tartu
Conditions: Type 2 Diabetes
Interventions: DRUG:GLP-1 receptor agonist; DRUG:SGLT2 inhibitor
Results posted: FALSE
Individual participant data sharing: NO

Registered primary outcomes

Urinary aldosterone at 3 months [3 months]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.